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Abstract
We hypothesized that the peptidoglycan component of B. anthracis may play a critical role in morbidity and mortality
associated with inhalation anthrax. To explore this issue, we purified the peptidoglycan component of the bacterial cell wall
and studied the response of human peripheral blood cells. The purified B. anthracis peptidoglycan was free of non-
covalently bound protein but contained a complex set of amino acids probably arising from the stem peptide. The
peptidoglycan contained a polysaccharide that was removed by mild acid treatment, and the biological activity remained
with the peptidoglycan and not the polysaccharide. The biological activity of the peptidoglycan was sensitive to lysozyme
but not other hydrolytic enzymes, showing that the activity resides in the peptidoglycan component and not bacterial DNA,
RNA or protein. B. anthracis peptidoglycan stimulated monocytes to produce primarily TNFa; neutrophils and lymphocytes
did not respond. Peptidoglycan stimulated monocyte p38 mitogen-activated protein kinase and p38 activity was required
for TNFa production by the cells. We conclude that peptidoglycan in B. anthracis is biologically active, that it stimulates a
proinflammatory response in monocytes, and uses the p38 kinase signal transduction pathway to do so. Given the high
bacterial burden in pulmonary anthrax, these findings suggest that the inflammatory events associated with peptidoglycan
may play an important role in anthrax pathogenesis.
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Introduction
During early stages of infections B. anthracis, spores are engulfed
by phagocytic cells which serve to traffic the organism to the
lymphatic system and bloodstream where severe disease ensues
due to rapid growth of the organism. Macrophages are thought to
be critical to both the early and late stages of this disease, with
distinct contributions to infection and progression of disease.
Indeed, when mice are depleted of macrophages and challenged
with B. anthracis spores, the animals have a shorter mean time to
death than those with a normal compliment of macrophages [1].
These studies suggest macrophages play a major role in defending
the host against the infection.
On the other hand, B. anthracis vegetative bacteria profoundly
expand during active infection, achieving 10
8–10
9 organisms per
milliliter of blood; [2,3]. The expansion is such that every organ
shows the presence of vegetative bacteria [4], as well as pleural
effusions [4] and cerebrospinal fluid [5]. The median incubation
from time of exposure to fulminate disease is rapid [4–6 days; [5]]
and infected patients have a poor prognosis, such that ,40% of
cases are fatal even with aggressive antibiotic therapy [4,5,6].
Therefore, given the high bacterial burden, it is also reasonable to
hypothesize that macrophages may contribute to sepsis and death
by releasing proinflammatory cytokines. Although previous studies
have focused extensively on the macrophage’s role in early
interactions with B. anthracis, very little is known about the
influence of B. anthracis on macrophage function during later stages
of disease. In particular the contribution of subcellular components
of B. anthracis to septic shock have not been elucidated.
Human septic shock is associated with increased levels of the
proinflammatory cytokines interleukin (IL)-1, tumor necrosis
factor a (TNFa) and IL-6 [7]. These cytokines are released when
human monocytes are stimulated with various Gram-negative and
Gram-positive bacteria strains [8]. Monocytes may respond to the
vegetative bacteria during B. anthracis infections by releasing
proinflammatory cytokines that contribute to septic shock and
death. Yet, the B. anthracis factors critical to proinflammatory
cytokine production have not been fully identified.
B. anthracis carries two virulence factors needed for toxemia
and/or for full pathogenicity. First, a poly-D-glutamic acid-
containing capsule provides B. anthracis with resistance to
phagocytosis by host myeloid cells [9]. The capsule is unique to
B. anthracis and is carried on a plasmid pXO2 [10]. Second, a
tripartite exotoxin is encoded on the plasmid pXO1. The proteins
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and edema factor. PA binds host cells and to lethal and edema
factors to form lethal toxin (LT) and edema toxin (ET) which are
internalized into host cells [11]. LT is a zinc metalloprotease that
cleaves mitogen-activated protein kinase kinases and thus
interferes with signal transduction processes leading to new gene
expression [12]. ET acts an adenylate cyclase that causes an
elevation in intracellular cyclic AMP, a condition that has been
shown to reduce the phagocytic ability of neutrophils [13].
Although injection of animals with the purified toxins of B.
anthracis cause death [14], the physiological relevance of the toxin
administered as a purified protein to death that accompanies
human infection by B. anthracis is not clear. First, cells within the
infected animals contact more than just the toxin proteins of B.
anthracis. Gram-positive organisms contain a rigid peptidoglycan
(PGN) cell wall that is reported to engage Toll-like receptors (TLR)
2 and 6 [15], the transmembrane peptidoglycan-recognition
proteins [16], and the nucleotide-binding oligomerization domain
(NOD) 1 and 2 proteins [17,18,19]. Agents that bind these
receptors on innate immune cells stimulate the production of
proinflammatory cytokines including IL-8 and TNFa [15,20].
Second, B. anthracis strains lacking LT and ET, when used to infect
mice, show a LD50 and a mean time to death that is not
significantly different from that of B. anthracis strains having
functional LT and ET [11]. Because of the high bacterial load in
infected individuals and the ability of other Gram-positive PGN
species to stimulate inflammation, the PGN of B. anthracis is a
potential virulence factor that has not been investigated for its role
in inflammation leading to septic shock. These findings in animal
models raise the possibility that septic shock may also be relevant
to human pathology. Therefore, the endogenous toxins present in
the B. anthracis cell wall may be important virulence factors.
The chemical composition of and host response to B. anthracis
PGN has not been characterized. PGN is a large glycan polymer
composed of alternating N-acetylglucosamine (GlcNac) and N-
acetylmuramic acid (MurNac) residues joined by short (4–5 L- and
D-amino acids, [21]) stem peptides [21]. The stem peptides can be
linked to each other either directly or through more complex
polypeptide bridges [21,22]. The glycan strand, the particular
stem peptide residues and their length, and the presence and
location of the interpeptide bridges can vary between species [22].
For example, S. aureus PGN shows a pentaglycine polypeptide
linking the stem peptides, the presence of which renders the PGN
sensitive to the protease lysostaphin [23].
A polysaccharide may be covalently bound to some Gram-
positive PGN molecule. The polysaccharide can be released by
hydrogen fluoride (HF)-mediated hydrolysis. The presence of the
polysaccharide can support the proinflammatory activity of PGN
of some Gram-positive species [24]. The PGN of B. anthracis is
known to contain a polysaccharide but its role in inflammation has
not been studied [25]. Additionally, lipoteichoic acid (LTA) and
teichoic acids may be associated with the PGN of Gram-positive
organisms. LTA is a negatively charged glycolipid with a
polyglycerol phosphate backbone and is anchored to the cell
membrane by the lipid unit [26]. LTA is a potent inducer of
proinflammatory cytokine release by innate immune cells [27].
Given the inflammation-inducing properties of PGN and its
associated components, we hypothesized that peptidoglycan of B.
anthracis has a role in the sepsis and death of the host that occurs in
the infection. This hypothesis predicts that PGN from B. anthracis
promotes the induction of proinflammatory cytokines in human
peripheral blood (PB) cells associated with the inflammation
during infections. To test this prediction, we purified the
uncharacterized B. anthracis PGN from vegetative bacteria. Using
this preparation, we found that B. anthracis PGN stimulated TNFa
production from whole blood, and that the monocytes were the
sole responding population. The biological activity in B. anthracis
PGN was not sensitive to DNase, RNase, or various proteases nor
to reagents that neutralize Gram-negative endotoxin. We also
found that PGN-mediated activation of p38 MAP kinase was
essential in the response. Our data indicate that PGN from B.
anthracis can initiate TNFa production through a pathway
involving p38 MAP kinase. These findings are consistent with
the notion that B. anthracis pathophysiology can be at least in part
due to septic shock of the host. These findings have important




B. anthracis crude cell wall extract was purchased from List
Biological Laboratories (Campbell, CA). Trypsin Gold, mass
spectrometry grade was purchased from Promega. DNase 1, Ultra
Pure E. coli lipopolysaccharide (LPS) and Polymixin B was purchased
from Invivogen (San Diego, CA). RNase A was purchased from
Qiagen. Brefeldin A, and antibodies to human CD14, CD16b, CD3,
CD19 and TNFa were purchased from eBioscience, San Diego, CA.
The Cambrex Limulus amebocyte lysate assay was purchased from
Lonza. The phospho-protein antibodies used for intracellular staining
were purchased from Cell Signaling (Danvers,MA) as Alexafluor488
or Alexafluor 647 conjugates, and were phospho-p38 MAP kinase
(Thr180/Try182), phospho-p44/42 (T202/Y204) and phospho-
SAPK/JnK (Thr183/Tyr185). MAP kinase inhibitors SB202190,
SP600125 and PD98095 were purchased from Calbiochem (San
Diego, CA). Bacillus subtilis lipoteichoic acid was purchased from
Sigma-Aldrich (Milwaukee, WI).
Isolation and analysis of B. anthracis PGN
B. anthracis Delta Sterne strain (lacking capsule and toxins) PGN
was prepared by the method described by Popov et al. [28], with
modifications as described [29]. Endotoxin-free water used
throughout. Tryptic soy broth plates were spread with 0.1 ml of
an overnight culture of B. anthracis. The plates were incubated
again overnight at 37uC and the bacteria were scraped from plates
with a small amount (,50 mls) of cold tryptic soy broth media.
Bacteria were washed in endotoxin-free water, resuspended in
5 ml 8% SDS and boiled for 30 minutes. The lysed cells were
centrifuged and the pellet was washed with endotoxin-free water to
removes SDS. The resulting material was resuspended in DNase1
buffer with 40 Units of DNase 1 and 7 Units RNase A and
incubated 15 min at room temperature. The DNase and RNase
were extracted by a second boiling in 4% SDS followed by three
endotoxin-free water washes, one wash with 2 M NaCl and six
additional endotoxin-free water washes. The final pellet was
suspended in endotoxin-free water and boiled for 5 minutes. The
pellet was dried, weighed, resuspended in endotoxin-free water
and stored at 4uC. Bacillus subtilis (ATCC 6051) PGN was
extracted by the same method, except that heat killed B. subtilis
(65uC, 1 hour) was used as the starting material.
For monosaccharide analysis, PGN was hydrolyzed with either
6 M HCl to quantitate amino sugars [30], or 4 M trifluoroacetic
acid (TFA) for 4 hrs at 80u C. [31] to quantitate neutral sugars.
Samples were dried by vacuum centrifugation and chromato-
graphed isocratically on a CarboPac PA-1 Dionex column in
15 mM NaOH. Sugars were quantitated by pulsed amperometric
detection using response factors determined from weighed
amounts of known sugars.
B. anthracis PGN
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Heparinized human PB was drawn by venipuncture with the
signed informed consent of human subjects according to a
protocol approved by the Oklahoma Medical Research Founda-
tion Institutional Review Board. Blood was diluted 1:3 with
Dulbecco’s Modified Eagle’s Medium. Diluted whole blood was
cultured for all experiments in non-tissue culture 24 well plates or
micro-centrifuge tubes.
Measurement of cytokines in PB supernatant
The PGN preparation, at concentrations described in the text,
was added to diluted blood in 24 well culture plates. The plate was
incubated at 37uC for various time periods and centrifuged for
collection of supernatant. Sandwich enzyme-linked immunosor-
bant assays (ELISA) for TNFa were performed on the superna-
tants as described [32]. Multiplex bead immunoassays were
performed on the supernatants using a Biosource Human
Cytokine 25-Plex (Camarillo, CA). The assay was analyzed on a
Luminex 100 with version 2.2 software (Luminex, Austin, TX).
Standard curves for cytokines were fit using Applied Cytometry
Systems STarStation 2.0 (Plano, TX).
Flow cytometry analysis
The surface markers CD14 and CD16b were tested for their
ability to identify monocytes by sorting cells based on CD14/
CD16b, CD3 and CD19 intensity, preparing slides, staining with
May-Grunwald Giemsa to confirm identity by morphology. The
cells were resuspended in 200 ml fluorescence-activated cell sorter
buffer [phosphate-buffered saline (PBS), containing 3% fetal calf
serum, 0.1% NaN3] and stained with antibodies to surface markers
(CD14, CD16b, CD19, and CD3). Cells were gated or sorted based
on forward scatter (FSC) and side scatter (SSC) and positive
fluorescent surface markers. A mutually exclusive lymphocyte gate
and monocyte/neutrophil were drawn on the FSC vs. SSC plot.
These serial gates (FSC/SSC and surface marker-positive fluores-
cent gates) were used in all subsequent experiments to identify the
various blood cell subpopulations. For analysis of cytokines, 3 mg/
ml Brefeldin A was added to cultures; in some experiments
Polymyxin B was added at a concentration of 10 mg/ml. After the
indicated stimulation time, the blood cells were transferred to
microfuge tubes and the plates were washed with PBS/Brefeldin A,
0.02% EDTA to collect adherent cells. Purified human IgG
(0.1 mg/ml) was added to block IgG receptors present on myeloid
and lymphoid cells. Cells were washed with PBS/Brefeldin A and
fixed for 20 minutes at room temperature with 100 mlP B S
containing 2% formaldehyde. The samples were permeabilized
with 0.5% saponin before staining with anti-TNFa antibodies
(2 mg/ml). Data were collected on 10,000 cells per sample. The
percent of TNFa positive cells was calculated using number positive
cells/total number of cells. For intracellular phospho-protein
staining, PB was stimulated with PGN or LPS (1 mg/ml) and
carried out essentially asdescribed [33].Briefly,cellswerefixed with
4% formaldehyde, surface stained with CD14-PE in buffer
containing 0.2 mg/ml purified human IgG to block IgG receptors,
resuspended in 1 ml permeabilization buffer (50% methanol; 0.56
PBS), and stained with anti-phospho MAP kinase antibodies in
buffer containing 0.2 mg/ml human IgG.
Treatment with modifying enzymes
The purified B. anthracis PGN was incubated for 24 hours at
37uC with each of the following modifying enzymes or buffers:
lysozyme (Sigma) 66 mg/ml; 2,758,000 U/ml); lysostaphin (Sigma)
150 mg/ml; $45 U/ml; DNase 1; 100 U/ml; RNase A 250 mg/
ml, trypsin 2.6 mg/ml; proteinase K (Sigma), 50 mg/ml. The
buffer for the lysozyme, lysostaphin, and trypsin digests was
0.02 M Tris-HCL, 0.05 M KCL (pH 8.4). For proteinase K
buffer, 1 mM Ca
2+ was added in the in the form of CaCl2. After
incubation, the hydrolytic enzymes were heat-inactivated 98uC
10 min, stored at 4uC, and the samples were used directly in the
assays without further manipulation.
Isolation of polysaccharide from PGN
HF hydrolysis of phosphodiester bonds and ethanolic precipita-
tion of the released polysaccharide was performed as described [34]
with modifications. To 1.3 mg dried PGN, 176 ml of 48% HF was
added andthe samplewassonicated 8 minutes tosuspend the PGN.
The sample was incubated at 4uC for 24 hours,centrifuged, and the
HF-soluble supernatant containingthe polysaccharide was removed
to a new tube. The supernatant was mixed with 100% ethanol to
precipitate the polysaccharide and centrifuged. The polysaccharide
pellet was washed three times with 100% ethanol and dissolved in
endotoxin-free water. The HF-insoluble PGN was washed 3 times
with endotoxin-free water. Both the HF-soluble and -insoluble
samples were air dried and redissolved in endotoxin-free water to
their original volume. The optical density at 600 nm was measured.
PGN concentration was determined using a standard curve of
commercial B. anthracis cell wall (List Labs) versus OD600.
Extraction of LTA
The procedure to purify LTA from B. anthracis was performed as
described [27] with the following modifications. B. anthracis Sterne
strain was grown to an OD of 0.6 in tryptic soy broth, resuspended
in 0.1 M sodium citrate buffer pH 4.7 and sonicated for
10 minutes before adding an equal volume of butanol and mixing
at room temperature for 30 minutes. After centrifugation, the
aqueous phase was lyophilized. Further purification of extracted
LTA was by hydrophobic interaction chromatography as
described [35], using a HiTrap
TM Octyl Sepharose FF 1 ml
column (Pharmacia). A linear gradient method was used with
solvent A (15% isopropanol, 100 mM ammonium acetate pH 4.7)
and solvent B (60% isopropanol, 100 mM ammonium acetate,
pH 4.7). One ml fractions were collected. The phosphate content
of PGN preparations and fractions from LTA purification was
measured as described [36].
Extraction of RNA and Quantitative PCR
Diluted PB, prepared as above, was stimulated for 2 hours with
PGN at 10 mg/ml. Samples were extracted with Trizol Reagent
(Invitrogen, Carlsbad, CA) and cDNA was synthesized using
Superscript First Strand Synthesis System for PCR (Invitrogen)
using 2 mg total RNA. Real-time quantitative PCR was performed
on 20 ml volumes using RT-PCR primer set for human TNF or
RT-PCR primer set for human ACTB (SuperArray Bioscience
Corporation, Frederick, MD), SYBR Green PCR Master Mix
(Applied Biosystems, Foster City, CA) and first strand DNA
template. DNA was amplified on the Real Time PCR System
7500 (Applied Biosystems, Foster City, CA): 10 mins at 95uC, 40
cycles of 95uC for 15 secs, 60uC for 1 min. Analysis of relative
gene expression was performed as described earlier [37].
Statistical analysis
Where applicable, the data were expressed as the mean-
s6standard errors of the means (SEM). Statistical significance was
determined by one-way analysis of variance (ANOVA) with
Bonferroni post test or by paired or unpaired t test. A p value of
,0.05 was considered significant.
B. anthracis PGN
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Analysis of B. anthracis PGN
We isolated PGN from B. anthracis cell walls by sequential SDS
extractions, hydrolysis of contaminating nucleic acids with RNase
and DNase, and high salt extractions. We first performed SDS/
PAGE analysis of the material under reducing conditions (5% b-
mercaptoethanol) to look for non-covalently bound proteins that
might contaminate the PGN preparation. The silver-stained gel is
shown in Figure 1A and demonstrates the complete absence of
proteins (lane 2). However, bacterial proteins were readily detected
in lysates of whole B. anthracis (Figure 1A lane 1). The data suggest
that the PGN preparation does not contain associated bacterial
protein, nor protein linked by disulfide bonds.
The purified PGN was assessed for amino acid content by acid
hydrolysis and HPLC analysis of the resulting amino acids
(Figure 1B). The most abundant amino acids (defined as
.0.2 nmoles/mgram of PGN) were alanine (0.36), glutamic acid
(includes glutamine) (0.34), aspartic acid (includes asparagine)
(0.22), and glycine (0.20) which are typical of the stem peptide and
polypeptide bridges in other Gram-positive organisms. We did not
distinguish L- and D-amino acids although both are reported to be
present in stem peptides and bridges [21]. The source of the minor
amino acids is not clear and could reflect the complexity of the B.
anthracis stem peptide, the presence of an interpeptide bridge, or
contaminating covalently-bound membrane protein. Alanine and
glutamic acid are abundant because they are major components of
stem peptides in other Gram-positive PGN species [21]. Glycine
may be abundant because it can be substituted in the a-carboxyl
unit of a D-glutamic acid residue of a stem peptide, as had been
shown for Micrococcus leuteus [21]. The presence of a significant
amount of aspartic acid suggests either a substitution in a stem
peptide or a polypeptide bridge containing aspartic acid similar to
that found in many species [21]. The other minor amino acids
may represent substitutions in stem peptides or may be bound to
stem peptide residues. In experiments described below we have
subjected this PGN preparation to various enzymatic treatments,
including proteinase K. We found that the amino acids present in
the PGN are essentially identical, before and after PGN digestion
with proteinase K (not shown).
PGN from B. anthracis and other Gram-positive organisms
contain a covalently-bound polysaccharide that is sensitive to HF
digestion [25]. To analyze the monosaccharides of the PGN
preparation, we treated PGN with HF to cleave phosphodiester
linkages. The digested material was centrifuged to separate the
HF-insoluble PGN fraction from the HF-soluble polysaccharide
fraction. These fractions were hydrolyzed in HCl to quantitate
amino sugars and TFA to quantitate neutral sugars. The
monosaccharides were resolved using high pH anion exchange
chromatography and electrochemical detection. We analyzed the
B. anthracis PGN preparation for monosaccharide composition
before and after HF-mediated removal of the polysaccharide,
followed by separation of the HF-insoluble PGN fraction from the
HF-soluble polysaccharide fraction (Table 1). As expected,
muramic acid was detected only in the insoluble fraction,
indicating that all of the PGN remained insoluble after HF
treatment. By comparison, the majority of galactose and
mannosamine (60%) was recovered in the soluble fraction.
Because galactose is exclusive to the polysaccharide in Gram-
positive organisms [25], this indicates that the majority of
polysaccharide was released by HF treatment. In addition to the
monosaccharides listed in Table 1, galactosamine was detected at
0.044 nmoles/mg PGN. Because galactosamine concentration was
low relative to the other monosaccharides, we could not
conclusively determine whether galactosamine is a constituent of
the polysaccharide or of the PGN backbone. Other monosaccha-
rides below this threshold were not detected.
TNFa is the predominant cytokine that increases in
peripheral blood cells in response to increasing
stimulation with PGN
To investigate the inflammatory response of human peripheral
blood (PB) cells to the B. anthracis vegetative PGN component of
the B. anthracis cell wall, we stimulated diluted whole human blood
for 6 hours with B. anthracis PGN and with LPS as a control. We
measured cytokines in the PB supernatant induced by stimulating
with PGN at 10 mg/ml. We found (Figure 2) that PGN induced
production of the cytokines TNFa, IL-6, IL-1 receptor agonist (IL-
1ra), IL-1b and granulocyte-macrophage colony stimulation factor
(GM-CSF) and the chemokines IL-8, monocyte inflammatory
protein (MIP) 1a and 1b, macrophage chemotactic protein
(MCP)-1, and Regulation upon Activation Normal T cell
Expressed and Secreted (RANTES). Since TNFa was the major
Figure 1. Purified peptidoglycan from B. anthracis lacks
noncovalently bound proteins. (A) Silver-stained SDS PAGE
showing with samples from purification steps and comparison to
commercial preparation. Lane 1: bacteria after harvest, lane 2:
equivalent sample of extracted PGN, lane 3: molecular weight marker.
(B) Amino acid content of B. anthracis PGN.
doi:10.1371/journal.pone.0003706.g001
Table 1. Monosaccharide composition of HF-hydrolyzed PGN










1 0.59 0.35 0.94
Glucose
1 0.52 0.24 0.76
Mannosamine
2 0.21 0.15 0.36
Glucosamine
2 0.98 1.9 2.9
Muramic acid
2 0.03 1.4 1.4
1Neutral sugar analysis based on Trifluoroacetic acid hydrolysis.
2Amino sugar analysis based on HCl hydrolysis.
3Total derived by mathematical addition of HF-hydrolyzed fractions.
doi:10.1371/journal.pone.0003706.t001
B. anthracis PGN
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production of TNFa to increasing doses of PGN (Figure 2C). For
doses $1.0 mg/ml, the TNFa concentration in the supernatant
was significantly different than in the unstimulated samples
(P,0.001; marked by *). Thus, cells within whole PB respond to
B. anthracis PGN by producing proinflammatory cytokines,
predominantly TNFa, and a number of chemokines that are
known to recruit innate immune cells. Because our hypothesis
predicts the induction of proinflammatory cytokines and TNFa is
an important proinflammatory mediator in disease [38], we
focused on the source of TNFa and the functional relationship
between B. anthracis PGN and the induction of TNFa.
Monocytes, not neutrophils or lymphocytes, produce
TNFa in response to PGN
To identify the cell populations within the complex cell mixture
of PB that were producing TNFa, we stimulated PB with PGN
and measured TNFa by intracellular cytokine staining. Unique
cell surface markers were used to identify monocytes, neutrophils
and lymphocytes. We first confirmed the validity of surface
markers used to gate the various PB cell populations by sorting the
antibody-stained PB. Sorting was based on forward scatter and
side scatter properties (FSC/SSC) and surface marker-positive
fluorescent gates; CD3 for T lymphocytes; CD19 for B
lymphocytes; CD14 in combination with CD16b to distinguish
monocytes and neutrophils. The sorted cells were stained with
May-Grunwald Giemsa and identified by morphology (Figure 3A).
For CD14+/CD16b2 cells, 100% (243/243) showed a morphol-
ogy consistent with monocytes; CD142/CD16b+ cells, 98.5%
(202/205) showed a neutrophil morphology. Likewise, CD19+
and CD3+ cells showed a lymphocyte morphology free of myeloid
cells (Figure 3B). All CD3+/CD19-cells were lymphocytes (230/
230) as were CD32/CD19+ cells (258/258).
Using this gating strategy, we applied intracellular cytokine
staining to determine the percentage of each unique cell
population that was producing TNFa in response to B. anthracis
PGN (Figure 3C). Surprisingly, we found that monocytes were the
sole source of TNFa when PB was stimulated with PGN (10 mg/
ml). Six hours after stimulation 33.2% of monocytes were positive
for intracellular TNFa, compared to ,1% of monocytes in
unstimulated blood (Figure 3D). TNFa production was insignif-
icant in neutrophils (CD142/CD16b+) and T and B lymphocytes
(CD3+, and CD19+) when stimulated with PGN; less than 2% of
cells in these populations were positive for TNFa. PB monocytes
responded in a dose-dependent manner to increasing doses of
PGN from 0.1 to 10 mg/ml (Figure 3E). The percent positive at 1,
5 and 10 mg/ml of PGN was 5%, 26% and 33%, respectively. At
doses above 5 mg/ml, the percent of CD14+/CD16b2 monocytes
positive for intracellular TNFa was significantly increased in
comparison with the unstimulated samples. Thus, monocytic cells
but not neutrophils or T or B lymphocytes respond to PGN
derived from B. anthracis by producing TNFa. As an additional
control, we stimulated the whole blood with PMA/ionomycin or
LPS and measured cytoplasmic interferon-gamma, TNF-b or
oncostatin M. We found that the T lymphocyte population
responded to PMA/ionomycin with an increase in interferon-
gamma while B lymphocytes produced TNF-b not shown). The
neutrophil population responded to LPS with an increase in
oncostatin M (not shown). Thus, these other blood cells can
respond to stimuli and the failure of these other cells to respond to
PGN is not for trivial reasons.
TNFa activity is not due to endotoxin, LTA, or bacterial
DNA, RNA, protein contamination of the PGN
preparation
The ability to stimulate TNFa production by the B. anthracis
PGN could be due to contamination of our PGN preparation by a
Gram-negative endotoxin or by DNA, RNA or proteins from B.
anthracis that are known to stimulate TLRs in mammalian cells
[15]. To test the possibility that something other than B. anthracis
PGN was responsible for the TNFa response in PB, we examined
the B. anthracis PGN preparation for endotoxin at the working
Figure 2. TNFa is the major cytokine in PB produced in response to B. anthracis PGN. PB was stimulated with either 10 mg/ml or increasing
doses of PGN for 6 hours. (A, B). Secreted cytokines (A) and chemokines (B) in PB supernatants were measured by human multiplex bead
immunoassay. Data are expressed as mean6SEM of 3 replicate wells. Statistical significance was determined for stimulated PB (PGN; 10 mg/ml) versus
unstimulated (NS) by unpaired, one-tailed t test; *, p,0.001 versus 0 PGN; #,p ,0.05 versus 0 PGN (C) Dose-response of secreted TNFa in supernatant
measured by ELISA. The data are expressed as mean6SEM of 3 replicate wells. Statistical significance was determined by ANOVA with Bonferroni post
test. *, p,0.001 versus 0 PGN.
doi:10.1371/journal.pone.0003706.g002
B. anthracis PGN
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We found that the PGN at 10 mg/ml had about 0.1 endotoxin unit
(EU)/ml endotoxin activity (Figure 4A) which corresponded to
10 pg/ml of E. coli LPS. We then tested this amount of E. coli LPS
to see if it would stimulate PB monocytes to produce TNFa and
found that this dose failed to stimulate TNFa production
(Figure 4B). To further assess a potential contribution of
endotoxin, PGN stimulation of TNFa production from whole
blood was performed in the presence of 10 mg/ml polymixin B.
While polymixin B reduced the mean fluorescence intensity (MFI)
of TNFa expression in monocytes by 44% in response to LPS, no
change was detected in the response to PGN in the presence of
polymixin B (Figure 4C). Thus, we conclude that the TNFa
response we measured in these experiments was not due to
contaminating Gram-negative endotoxin. To test for other
potential TLR-stimulating material contaminating the B. anthracis
PGN, we treated the PGN with various hydrolytic enzymes.
Lysozyme digests the glycosidic bonds of the PGN backbone
[23,39]. Lysostaphin specifically digests the pentaglycine bridge of
the stem peptide present in Staphylococcus PGN and reduces the
cytokine response [39]. DNase and RNase digest CpG and
bacterial RNA that could stimulate TLR9 and 3, respectively.
Trypsin and proteinase K digest proteins that might contaminate
our PGN preparation and could stimulate an unknown pattern
recognition receptor in monocytes. Of these hydrolytic enzymes,
only lysozyme was able to reduce the TNFa-stimulating ability of
the PGN from B. anthracis (Figure 4D). None of the enzymes or
buffers alone induced TNFa (data not shown). It should be noted
that D-amino acids commonly present in the stem peptide are
resistant to these enzymes, but D-amino acids are absent from
bacterial proteins [40]. The findings indicate that the TNFa
response was not due to contaminating DNA, RNA or proteins
and required the intact glycan chain of PGN that is sensitive to
lysozyme.
Contamination with LTA has been a factor in studies of the
immunostimulatory properties of PGN preparations from Gram-
positive bacteria [41], although there have been no reports of LTA
in B. anthracis [42]. LTA is a polymeric chain composed of units of
an alkane (glycerol or a monosaccharide) joined to phosphoric acid
by phosphodiester bonds and hence is rich in organic phosphate
[26]. We compared the phosphate content of B. anthracis PGN to
an equivalent PGN preparation from an organism known to have
LTA, B. subtilis [ATCC6051; [35]]. We found that the B. anthracis
PGN had an 8-fold lower phosphate content than PGN of B.
Figure 3. Monocytes produce TNFa in response to PGN. (A) Blood cells were sorted by SSC/FSC properties and staining intensity of fluorescent
surface markers CD14, CD16b, CD3, CD19. Cells were separated as CD14+/CD16b2 (monocytes), CD142/CD16b+ (neutrophils) (A), CD19+ (B
lymphocytes), CD3+ (T lymphocytes) (B). Slides were prepared of the sorted subpopulations. Leukocyte type was determined based on nuclear and
cytoplasmic stain and morphology. (C) TNFa positive cells were identified using surface markers as above, in combination with intracellular staining
for TNFa. (D) PB was stimulated with PGN (10 mg/ml) for 2, 4 and 6 hours. Cell populations were identified by surface markers and TNFa was
measured by intracellular staining and flow cytometry. Two separate preparations from two donors were used; for the 6 hour point, five preparations
were used. (E) PB was stimulated with PGN and the percent TNFa+monocytes (CD14+/CD16b2) was measured after 6 hours at each dose by
intracellular staining and flow cytometry. Three separate preparations from two donors were used. For PGN (10 mg/ml), five preparations were used.
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We also extracted B. anthracis with butanol and subjected the
aqueous phase to hydrophobic interaction chromatography,
eluting with increasing concentrations of isopropanol. Using this
procedure, we were able to detect an authentic, commercial LTA
isolated from the related species B. subtilis using an organic
phosphate assay, but no LTA was detected from B. anthracis
extracts (data not shown). The finding suggests that B. anthracis
lacks LTA and it is therefore unlikely that the induction of TNFa
we describe above is due to LTA. Additionally, cleavage of
phosphodiester bonds by HF, a procedure that efficiently
hydrolyzes LTA [27], did not reduce TNFa induction by PGN
(see below).
The PGN-associated polysaccharide is not necessary for
TNFa activity
The PGN-associated polysaccharide in B. anthracis is unique to
B. anthracis among several closely related species [25]. We
determined whether the PGN-associated polysaccharide was
necessary for TNFa induction by digesting the PGN with HF to
remove the polysaccharide from the insoluble PGN. Monosac-
charide analysis showed that HF digestion removed the polysac-
charide from the PGN backbone (Table 1). The digestion yielded a
HF-soluble fraction and the HF-insoluble fraction containing the
PGN backbone. We sonicated B. anthracis PGN to improve its
suspension during the HF digestion, and therefore also examined
the effect of sonication on TNFa production by monocytes. We
then tested both HF-insoluble (containing the PGN) and HF-
soluble (containing the polysaccharide) fractions for their ability to
induce TNFa. To compensate for a loss of mass during the HF
digestion and washes, we report the data as the percent of TNFa+
monocytes per mg of solid material that remained. We found
(Figure 5) that only the fraction containing the HF-digested PGN
was able to induce TNFa. The loss of activity in the
polysaccharide containing HF-soluble fraction was not due to
sonication, since sonicated PGN retained 100% of its biological
activity (Figure 5). The data indicate that the ability of B. anthracis-
derived PGN to induce TNFa in human monocytes requires only
the PGN component and not the bound polysaccharide. The fact
that the HF-digested PGN was as efficacious as undigested PGN
shows that LTA is not contributing to the TNFa induction, since
HF also hydrolyzes any LTA that might also be present [27].
TNFa is produced through a p38 MAP kinase pathway
To explore the signal transduction pathway stimulated by PGN
in monocytes and leading to TNFa production, we tested whether
MAP kinases in monocytes were stimulated by PGN. As in the
experiments in Figure 3, we used diluted whole PB stimulated with
10 mg/ml PGN for 15 minutes. The cells were fixed and stained
with fluorochrome-labeled antibodies to CD14 to gate on
monocytes, and co-stained with commercially labeled antibodies
to phosphorylated forms of MAP kinase proteins: phospho-p38,
phospho-p44/42 Erk kinase and phospho-Jun kinase (JnK). We
gated on CD14+ cells and generated histograms of the phospho-
MAP kinase levels of the unstimulated or stimulated cells. The
histograms are shown in Figure 6A–D and a summary of 3
experiments is shown in Figure 6E. We found that phospho-p38
MAP kinase and phospho-Erk MAP kinases were significantly and
consistently increased by 1.8 fold and 3 fold, respectively, while
phospho-JnK was not increased. Thus, stimulation of monocytes
with PGN causes activation of the MAP kinase pathways involving
ERK and p38 but not JnK.
To explore whether activation of these MAP kinase pathway(s)
are required for TNFa production, we tested the effects of the
MAP kinase inhibitors SB202190 (a p38 MAP kinase inhibitor),
Figure 4. Production of TNFa is not due to endotoxin, bacterial
DNA, RNA or contaminating proteins in B. anthracis peptido-
glycan. A) The Limulus amebocyte lysate assay was used to test PGN
(10 mg/ml), LPS (1 pg/ml, 10 pg/ml, 100 pg/ml) and endotoxin-free
water for endotoxin activity, Endotoxin units (EU)/ml. Data are
expressed as mean6SEM of 3 replicates. Statistical significance was
determined for LPS (10 pg/ml) compared with PGN (10 mg/ml) by
unpaired, two-tailed t test; p=0.49, indicating no significant difference
in level of endotoxin activity. (B) PB was stimulated with 10 pg/ml LPS
6 hours and TNFa positive monocytes were measured by flow
cytometry. (C) PB was stimulated with PGN or LPS with and without
polymixin B (PMB) (10 mg/ml) to bind endotoxin. TNFa production is
expressed as fold difference6SEM of MFI of TNFa positive monocytes
for 2 separate preparations on two individuals, 2 replicates each.
Statistical significance was determined by ANOVA with Bonferroni post
test. *, p,0.001 versus 1 mg/ml LPS without PMB. (D) B. anthracis PGN
was digested with the indicted hydrolytic enzymes for 24 hours. The
preparations were heat inactivated and used to stimulate PB at 10 mg/
ml PGN along with an equivalent preparation of untreated PGN. The
percent of TNFa positive monocytes was measured by intracellular
cytokine staining. Data are expressed as the mean6SEM of three
separate preparations. Statistical significance was performed on results
from the enzyme treated PGN stimulations versus stimulation with
untreated PGN by ANOVA with Bonferroni post test. *, p,0.001 versus
untreated PGN.
doi:10.1371/journal.pone.0003706.g004
Figure 5. The PGN-associated polysaccharide of B. anthracis is
not necessary for TNFa activity. B. anthracis PGN was sonicated and
hydrolyzed with HF for 24 hours. The HF-soluble polysaccharide was
separated from the insoluble peptidoglycan backbone by centrifuga-
tion. The original PGN, sonicated PGN, and HF-soluble polysaccharide
and HF-insoluble PGN fractions were used to stimulate PB. The percent
TNFa positive monocytes was calculated per mg of PGN (OD600). Data is
expressed as mean6SEM of three separate preparations from 2 donors
including two separate HF hydrolysis reactions of PGN. Statistical
analysis was by ANOVA with Bonferroni post test of the stimulated
samples versus PGN. *, p,0.001 versus PGN.
doi:10.1371/journal.pone.0003706.g005
B. anthracis PGN
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these experiments, PB were stimulated with 10 mg/ml PGN in the
presence of the each inhibitor. TNFa was measured by
intracellular cytokine assay after 2 hours and a summary of 3
separate experiments is shown in Figure 6F. PGN stimulated
about 20% of monocytes to express TNFa protein in the absence
of MAP kinase inhibitors and 3.3% in the presence of 10 mMo f
the p38 MAP kinase inhibitor. The other MAP kinase inhibitors
did not notably reduce TNFa production induced by PGN.
Inhibition of Erk slightly reduced the number of TNFa positive
cells but the effect was not statistically significant. We confirmed
this result by repeating the PGN stimulation in the presence of
inhibitors and harvesting PB supernatants for analysis by multiplex
bead immunoassay as described in the Materials and Methods.
Inhibition of p38 MAP kinase caused a 96% reduction in TNFa
(p,0.01 by ANOVA with Bonferroni post test), while inhibition of
the Erk and JnK caused no significant difference in TNFa
(p.0.05, data not shown). Thus, although the ERK pathway is
induced by B. anthracis PGN, it is not required for production of
TNFa. Of the three MAP kinase pathways, the p38 pathway is
critical to TNFa production.
PGN induces expression of TNFa mRNA in PB
The appearance of TNFa in the supernatant of PGN-stimulated
PB cells might be due to secretion of pre-existing protein, to
increases in TNFa mRNA levels, and/or to mRNA stabilization
[43]. To distinguish these possibilities, we determined whether
TNFa mRNA expression is increased with PGN stimulation. We
first applied a time course to determine the period after stimulation
of diluted whole PB with 10 mg/ml PGN that produced the
maximum TNFa protein. Maximum TNFa production occurred
between 6 and 12 hours after stimulation (Figure 7A). Based on
this finding, we extracted total RNA from PB six hours after
stimulation and generated cDNA from total RNA. The cDNA was
applied to a quantitative real-time PCR assay to measure relative
levels of TNFa mRNA. We used b-actin mRNA as a standard to
control for the amount of cDNA applied to the stimulated and
unstimulated samples. We found a 40-fold increase in TNFa
mRNA expression in the PGN-stimulated PB compared to
unstimulated PB (Figure 7B). The reference gene, b-actin, was
used to normalize the mRNA level since it showed no change in
expression in PGN stimulation PB relative to unstimulated PB.
The increase was largely blocked by inclusion of the p38 inhibitor.
The result suggets that PGN stimulation induces a significant
increase in TNFa mRNA in a p38-dependent way, and strongly
suggest that the TNFa protein produced in response to PGN is
due to nascent synthesis of TNFa. To measure the contribution of Figure 6. PGN stimulates the p38 MAP kinase and ERK
pathways and TNFa is blocked by inhibition of p38 MAP
kinase. (A) PB was stimulated with PGN (10 mg/ml) or LPS (1 mg/ml)
and phospho-MAP kinases were measured by intracellular staining in
CD14+ monocytes. (B) Phospho-p38 MAP kinase was measured after
15 min for the unstimulated (thin solid line), PGN (thick solid line), and
LPS (dashed line). (C) Phospho p44/42 MAP kinase, 15 minutes and (D)
phospho-JnK, 15 minutes. (E) Fold increase in phospho-MAP kinases for
unstimulated (NS), PGN and LPS stimulation. Data are expressed as
mean6SEM of three separate PB preparations. Statistical analysis was
performed on MFI of stimulated PB versus MFI unstimulated PB. *,
p,0.03; # p,0.005 by paired one-tailed t test. (F) PB was co-stimulated
for 2 hours with PGN (10 mg/ml) with the MAP kinase inhibitors
SB202190 (p38 MAP kinase inhibitor), SP600125 (JnK inhibitor) and PD
98095 (ERK inhibitor). TNFa in monocytes was measured by intracellular
staining and flow cytometry. Data are expressed as mean6SEM of three
separate preparations from two donors. Statistical analysis was by
ANOVA with Bonferroni post test. *, p,0.01 versus PGN (10 mg/ml).
doi:10.1371/journal.pone.0003706.g006
Figure 7. TNFa protein and mRNA is upregulated by PGN. (A)
Time course of secreted TNFa induced by PGN in whole blood. PB was
stimulated with PGN (10 mg/ml) and the supernatant was sampled at
the indicated times. TNFa concentration was measured by ELISA. Data
are expressed as mean6SEM for 3 replicates. Statistical analysis was by
ANOVA with Bonferroni post test. *, p,0.001 versus 0 PGN; #,p ,0.01
versus 0 PGN. (B) PB was stimulated with PGN (10 mg/ml)6SB202190 for
2 hours. RNA was isolated from leukocytes, converted to cDNA which
was subjected to real-time quantitative PCR. Gene specific primers used
were for TNFa and b-actin in a real-time PCR assay. Data presented are
the mean6SEM of separate preparations of the TNFa/b-actin ratio from
4 individuals, 3 replicates each and normalized to the unstimulated
ratio. Statistical analysis was by t test. *, p,0.01 for TNFa, PGN versus
unstimulated; # p.0.3 for b-actin versus unstimulated. (C) PB was
stimulated with PGN (10 mg/ml) for 3 hours. Cells were harvested to
represent 100% RNA at 3 hours. To equivalent samples, actinomycin D
was added immediately to block further RNA synthesis, or actinomy-
cin+SB202190 were added to block RNA synthesis and the p38 MAP
kinase pathway. Cells were harvested at 10, 20, 30, 60 minutes after
these additions. RNA was isolated, cDNA was prepared and subjected to
real-time quantitative PCR for TNFa as in (B). Quantity of RNA was
expressed as % of RNA after 3 hours of stimulation. Data presented are
the mean6SEM from 3 replicate PCR reactions from 1 individual.
Statistical analysis was by ANOVA with Bonferroni post test of *,
p,0.001 for PGN+ActD versus PGN+ActD+SB; #,p ,0.01.
doi:10.1371/journal.pone.0003706.g007
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PGN and added actinomycin D to prevent continued new mRNA
synthesis. The p38 inhibitor SB 202190 [44] was added to some
samples and the amount of remaining TNFa mRNA was
measured by real-time quantitative PCR. We found (Figure 7C)
that the TNFa mRNA decay in the presence of the p38 inhibitor
was greatly accelerated relative to the decay rate in the absence of
the inhibitor. These data strongly suggest that the p38 MAP kinase
pathway contributes to TNFa mRNA production as well as TNFa
mRNA stability to support TNFa production in PGN-stimulated
monocytes.
Discussion
We hypothesized that human PB would display a proinflam-
matory response upon stimulation with the B. anthracis PGN. We
tested this hypothesis by extracting and purifying PGN, stimulat-
ing human PB and measuring secreted cytokines including TNFa,
intracellular TNFa in hematopoietic cells of PB, and TNFa
messenger RNA in the responding cells. Secreted TNFa was
significantly increased in PB supernatant compared to unstimu-
lated blood, with the greatest rate of accumulation of protein
between 6 and 12 hours after stimulation. Surprisingly, monocytes
were the major and possibly the sole source of TNFa. Intracellular
TNFa and TNFa mRNA was significantly increased in monocytes
when measured from 2–6 hours after stimulation. The biological
activity of B. anthracis PGN was not due to the associated
polysaccharide nor to contaminating endotoxin, or bacterial
protein or nucleic acids, since it was insensitive to chemical
hydrolytic or neutralizing agents that removed these TLR ligands.
The production of TNFa appeared to be due to nascent mRNA
and protein synthesis and required the activation of the p38 MAP
kinase pathway to stabilize TNFa mRNA. The data establish that
the PGN of B. anthracis is indeed an important endogenous toxin
that is able to stimulate inflammation and the pathogenic effects
associated with inflammation. When present at the high
circulating amounts that are reported to occur in inhalation
anthrax, the contribution of the PGN to the pathology of the
infection is likely very high.
Although monocytes are the only cell type in PB that produce an
early TNFa response to B. anthracis PGN, neutrophils and
lymphocytes are capable of producing TNFa in response to various
stimulants. T lymphocytes produce TNFa after infection with
influenza virus [45], and B lymphocytes produce TNFa after
stimulation of the B cell antigen receptor and CD40 [46]. Human
neutrophils produced TNFa in response to LTA from S. aureus [47]
and E. coli LPS [48]. The fact that our flow cytometry data showed
that neutrophilsarenot asignificantsourceofTNFainducedbyour
PGN preparation is additional evidence that the activity in the B.
anthracis PGN preparation described here is not due to LTA
contamination. Thus, although other hematopoietic cells in PB are
capable of producingTNFa in response to various infectiousagents,
onlymonocytesrespond toB.anthracisPGN. Thisfact maybe dueto
the expression of a unique subset of Toll-like or other pattern
recognition receptors on monocytes that are absent from lympho-
cytes or neutrophils. The unique ability of monocytes to mount an
early inflammatory response to B. anthracis PGN has important
implications for therapies that aim to block B. anthracis sepsis at the
stage when the vegetative cell has disseminated to the PB.
Monocytes are the most important target for reducing the
inflammatory response that may lead to septic shock.
An earlier report showed isolated monocytes pre-activated with
interferon-c produce TNFa in response to non-purified cell wall
extracts of B. anthracis [28]. However, our study offers several
improvements. First, ex vivo stimulation of whole unmanipulated
peripheral blood, relative to stimulation of isolated and pre-
activated monocytes, provides a more accurate representation of
the in vivo responses. Indeed, experiments have shown that the
presence of autologous red blood cells with cultured blood-derived
lymphocytes and monocytes altered the production of cytokines
relative to that produced by isolated lymphocytes and monocytes
[49]. TNFa and interferon-c were reported to be produced at
higher levels when the monocytes are present in whole peripheral
blood environment relative to isolated monocytes [50]. Second,
supplements added to media used for culturing isolated cells could
skew the biological response of the cells. For example, stimulation of
T cells in serum-supplementedmedium enhanced production of IL-
2 and IL-4 and while depressing secretion of IL-4, IL-5 and
interferon-c, compared with cells in serum-free media [51]. In our
experiments, the cells are resting and are present in the endogenous
milieu of whole blood. This situation more closely mimics the state
of the monocytes in vivo when they encounter the cell wall of B.
anthracisastheorganismentersthe peripheralbloodduringanactive
anthrax infection. Lastly, our PGN preparation was extensively
purified andtestedfornumerouscontaminantsthanthepreparation
previously used to stimulate monocytes [28]. Specifically, we
demonstrate using a test for endotoxin contamination, the use of
polymixin B, and the application of a variety of hydrolytic enzymes
and chemicals, that the biologically active material in our purified
PGN preparation was PGN and not other bacterial substance such
as bacterial DNA, RNA, or protein, or LTA.
Our data indicates that the glycan chain of the PGN is an
important factor in the induction of TNFa in human monocytes.
Hydrolysis of the glycosidic linkages of the PGN murein core with
lysozyme caused a significant reduction in the TNFa production
stimulated by PGN. Digestion with lysostaphin, which hydrolyzes
the interpeptide bridge connecting the stem peptides in S. aureus
PGN, did not reduce TNFa. This finding suggests that B. anthracis
PGN lacks a pentaglycine bridge linking the stem peptide that is
present in S. aureus PGN. Other Gram-positive organisms use
instead a direct crosslink between diaminopimelic acid and
another amino acid in the stem peptide of the adjacent glycan
chain [21,23]. We isolated diaminopimelic acid in the B. anthracis
PGN preparation, consistent with lack of a pentaglycine bridge.
The presence of significant aspartic acid levels (see text) may
suggest a bridge containing aspartic acid rather than a direct cross-
link with diaminopimelic acid. Other protease digestions of PGN
with trypsin and proteinase K likewise did not reduce TNFa
production. The amino acid sequence of the stem peptide in B.
anthracis PGN is not known, thus its protease sensitivity is unclear.
However, other proteins covalently associated with PGN should be
susceptible to digestion by trypsin or proteinase K. The fact that
protease digestion did not affect the biological activity of B.
anthracis PGN is consistent with our interpretation that the PGN
glycan chain and/or stem peptide itself is the biological agent that
stimulates proinflammatory cytokine production, rather than
potential bacterial proteins associated with it.
The PGN of B. anthracis is known to have a major
polysaccharide bound to it by a phosphodiester bond that can
be released by treatment with HF [25,34,52]. The polysaccharide
consists of galactose, GLcNac and MurNac in a 3:2:1 ratio [25,34]
or 10:2:1 ratio [52]. Treatment of B. anthracis PGN with HF
isolated a polysaccharide containing glucosamine, galactose and
mannosamine in a ratio of 5:3:1 (Table 1). Hydrolysis of the
polysaccharide with HCL or trifluoroacetic acid removes the
acetyl groups from these monosaccharides, so N-acetyl glucos-
amine appears as glucosamine and N-acetyl mannosamine as
mannosamine in our analysis. Our results are consistent with
B. anthracis PGN
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present in the polysaccharide. Our result differs in that
glucosamine is present in greater quantity relative to galactose.
This difference may have resulted from a difference in hydrolysis
methods or analytical methods. Alternatively, variations in growth
conditions for B. anthracis may alter the composition of the major
polysaccharide in vegetative cells. In any case, although the
authors of an earlier study of B. anthracis polysaccharide speculated
that it may be proinflammatory [25], the polysaccharide we
isolated had no detectable biological activity. Our results are
consistent with previous evidence from S. aureus that the
proinflammatory properties peptidoglycans depend on the intact
glycan backbone of PGN [39,53].
Pathogen components including B. anthracis PGN and Gram-
negative LPS are sensed by the innate immune system through
TLRs. There is evidence that TLR2 and TLR6 recognize PGN of
Gram-positive organisms [15]. However, other studies have shown
that the ability of TLR2 to engage Gram-positive PGN is reduced
by trypsin digestion, suggesting that the TLR2 ligand might be a
contaminating bacterial protein or a trypsin-sensitive stem peptide
[54]. NOD2 has been shown to recognize lysozyme-digested PGN
of S. aureus but not polymeric PGN [54]. Some studies report that
N-acetylmuramic acid carrying two stem peptides, MurNac-L-
Ala-D-isoGln, is recognized by NOD2 [18] and induces proin-
flammatory cytokines, but the response depends on the bacterial
species from which the ligand is isolated [55]. We are currently
trying to identify the PGN receptor on human monocytes.
However, we note our finding (Figure 4) that human monocytes
recognize B. anthracis PGN digested with trypsin and proteinase K,
but not lysozyme-digested PGN. These data suggest the
unidentified human B. anthracis PGN receptor recognizes poly-
meric PGN to induce TNFa, but does not exclude a second
receptor that can recognize digested products of PGN.
A poly-D glutamic acid capsule provides B. anthracis with
resistance to phagocytosis by host myeloid cells [9]. It could be
argued that the poly-D-glutamic acid capsule prevents the innate
immune system from contacting the PGN. However, there are two
studies that indicate the vegetative cell wall of B. anthracis is indeed
exposed to the immune system, despite the presence of the capsule.
First, sera from animals vaccinated with B. anthracis Sterne strain
were able to stain the ends and septa of encapsulated Ames strain
B. anthracis obtained from bacteremic pig blood [56]. Since
antibodies in sera are accessible to encapsulated B. anthracis, the
PGN in the encapsulated B. anthracis may similarly be exposed to
monocyte pattern recognition receptors as it circulates. Second,
the PGN is processed as an antigen in animals during an active
infection with encapsulated B. anthracis. Rabbits immunized with
B. anthracis Vollum strain, having the capsule and toxin, form
antibody titers to a variety of cell wall proteins, covalently and
non-covalently bound, in equal levels with antibodies to LF and
secreted proteins [57]. This finding indicates that the capsule does
not prevent components of the cell wall from exposure to TLRs,
NOD receptors, or other receptors on cells of the immune system.
Inhibition of p38 MAP kinase provided a complete block of
TNFa production from PGN-stimulated monocytes. Studies on
LPS-induced TNFa production suggested the p38 pathway
affected translation but not transcription of TNFa mRNA since
p38 inhibition blocked LPS-triggered TNFa protein but not
mRNA production [58]. The notion that p38 regulates TNFa
translation but not transcription is consistent with other reports
showing that TNFa mRNA was stabilized by activation of p38
MAP kinase [59]. In addition to PGN, the secreted LT is another
factor affecting p38 MAP kinase during anthrax infection. LT
inactivates p38 MAP kinase by cleaving the upstream MAP kinase
kinases [60] and LT cleaves MAP/ERK kinase-1 [61]. The
production of LT may be an evolutionary strategy by B. anthracis to
prevent production of proinflammatory cytokine by the host
immune cells. Further dissection of the regulatory activity of
individual virulence factors on proinflammatory cytokines will
likely illuminate mechanism of sepsis, septic shock and host death
in B. anthracis.
Traditional notions about anthrax disease have focused on LT
as the cause of toxic shock and death. However, toxin-null B.
anthracis stains are lethal in mice [11]. If toxic shock is not a major
cause of death, inflammation and septic shock may contribute. A
significant inflammatory response, including secreted TNFa,i s
observed in baboons challenged with anthrax, although the
contribution of toxin to this response has not been determined
[62]. TNFa is a major contributor to sepsis, especially if not
modulated by anti-inflammatory mediators [63]. The secretion of
TNFa from monocytes stimulated with PGN is consistent with a
model of anthrax as a septic disease. Our results define p38 MAP
kinase and monocytes as a potential therapeutic target for
intervening in the B. anthracis inflammatory process that leads to
septic shock. Several p38 MAP kinase inhibitors are being
explored as agents against arthritis and septic shock [59,64].
These inhibitors may be useful adjuvant therapies in the treatment
of anthrax.
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